How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read Pharma Industry News Regencell Bioscience surges 9.86% amid low-float frenzy, but fundamentals remain Regencell Bioscience (RGC) jumps 9.86% to $342.99 on low volume. Find out what’s driving the surge—and why institutions are still staying away. byPallavi MadhirajuMay 15, 2025